GlucoTrack Inc (GCTK)
2.05
-0.14
(-6.39%)
USD |
NASDAQ |
Jun 26, 09:35
GlucoTrack Cash from Investing (Quarterly): -0.059M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.059M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.005M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -0.004M |
| March 31, 2022 | |
| December 31, 2021 | -0.004M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.003M |
| March 31, 2021 | |
| December 31, 2020 | -0.007M |
| September 30, 2020 | -0.031M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.015M |
| December 31, 2019 | -0.0004M |
| September 30, 2019 | -0.0126M |
| June 30, 2019 | -0.0035M |
| March 31, 2019 | -0.0064M |
| December 31, 2018 | 0.0083M |
| September 30, 2018 | -0.0118M |
| June 30, 2018 | -0.001M |
| March 31, 2018 | -0.0009M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0146M |
| June 30, 2017 | -0.0034M |
| March 31, 2017 | -0.0015M |
| December 31, 2016 | -0.0012M |
| September 30, 2016 | -0.0289M |
| June 30, 2016 | -0.0224M |
| March 31, 2016 | -0.024M |
| December 31, 2015 | -0.0842M |
| September 30, 2015 | -0.0758M |
| June 30, 2015 | -0.0311M |
| March 31, 2015 | -0.0121M |
| December 31, 2014 | -0.012M |
| September 30, 2014 | -0.0316M |
| June 30, 2014 | -0.0391M |
| March 31, 2014 | -0.0089M |
| December 31, 2013 | -0.0126M |
| September 30, 2013 | -0.0154M |
| June 30, 2013 | -0.0755M |
| March 31, 2013 | -0.0008M |
| December 31, 2012 | -0.0044M |
| September 30, 2012 | -0.0034M |
| June 30, 2012 | 0.0055M |
| March 31, 2012 | -0.0155M |
| December 31, 2011 | 0.0293M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.059M
Minimum
Mar 2024
0.005M
Maximum
Dec 2022
-0.0071M
Average
-0.0002M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -47.30M |
| Retractable Technologies Inc | -0.5027M |
| Xtant Medical Holdings Inc | -0.674M |
| Asensus Surgical Inc | 3.00M |
| Catheter Precision Inc | -0.022M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.942M |
| Free Cash Flow | -8.246M |
| Free Cash Flow Per Share (Quarterly) | -0.6012 |
| Free Cash Flow Yield | -87.03% |